Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2025-12-30 @ 10:39 AM
Study NCT ID:
NCT00454051
Status:
COMPLETED
Last Update Posted:
2011-08-08
First Post:
2007-03-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-12
Start Date Type:
None
Primary Completion Date:
2008-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-03-28
First Submit QC Date:
None
Study First Post Date:
2007-03-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-12-03
Results First Submit QC Date:
None
Results First Post Date:
2011-08-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-08-02
Last Update Post Date:
2011-08-08
Last Update Post Date Type:
ESTIMATED